Literature DB >> 1534701

Mesangiocapillary glomerulonephritis.

G D'Amico1, F Ferrario.   

Abstract

The clinical and histological features of idiopathic mesangiocapillary glomerulonephritis (MCGN) have been reviewed, with a survey of the most recent literature, including the retrospective analysis of the data of the Italian Study Group of Renal Immunopathology on 368 patients. In both major types of MCGN, six morphological variants have been characterized (classical MCGN, nodular MCGN, exudative MCGN, focal segmental MCGN, MCGN with massive deposits, and crescentic MCGN) that have different etiologic, pathogenetic, or clinical outcome correlates. Actuarial renal survival 10 yr after renal biopsy has been calculated with life-table analysis to be 60 to 65% in type I MCGN, without significant differences between treated and untreated patients; none of the therapeutic regimens tested up to now for this disease have been independently demonstrated to be efficacious. As for the pathogenesis, the interrelationships between the three mechanisms that contribute to the development of the morphological features of the disease (accumulation of electron-dense deposits on the subendothelial side of the glomerular basement membrane or within the glomerular basement membrane; mesangial proliferation and peripheral interposition; and inflow of inflammatory cells, mainly monocytes) have been discussed, and the role of hypocomplementemia and circulating nephritic factors (NFa and NFt) has been analyzed. Available evidence suggests that MCGN is an immunocomplex-mediated disease, the deposition of immune deposits being the initiating phenomenon, whereas the morphologic changes and complement system activation are secondary events.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1534701     DOI: 10.1681/ASN.V210s159

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  12 in total

1.  Cryoglobulinemic glomerulonephritis in thymic stromal lymphopoietin transgenic mice.

Authors:  S Taneda; S Segerer; K L Hudkins; Y Cui; M Wen; M Segerer; M H Wener; C G Khairallah; A G Farr; C E Alpers
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

2.  A novel mouse model of podocyte depletion.

Authors:  L Wang; Y Tang; D N Howell; P Ruiz; R F Spurney
Journal:  Nephron Exp Nephrol       Date:  2012-10-19

3.  Extensive complement activation in hereditary porcine membranoproliferative glomerulonephritis type II (porcine dense deposit disease).

Authors:  J H Jansen; K Høgåsen; T E Mollnes
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

4.  C3 nephritic factor associated with C3 glomerulopathy in children.

Authors:  Camille Nicolas; Vincent Vuiblet; Veronique Baudouin; Marie-Alice Macher; Isabele Vrillon; Nathalie Biebuyck-Gouge; Maud Dehennault; Sophie Gié; Denis Morin; Hubert Nivet; François Nobili; Tim Ulinski; Bruno Ranchin; Maria Chiarra Marinozzi; Stéphanie Ngo; Véronique Frémeaux-Bacchi; Christine Pietrement
Journal:  Pediatr Nephrol       Date:  2013-09-26       Impact factor: 3.714

5.  Remission of resistant MPGN type I with mycophenolate mofetil and steroids.

Authors:  Sudarsana De; Dana Al-Nabhani; Paul Thorner; Daniel Cattran; Tino D Piscione; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2008-10-30       Impact factor: 3.714

6.  Response of type I membranoproliferative glomerulonephritis to pulse methylprednisolone and alternate-day prednisone therapy.

Authors:  J M Bergstein; S P Andreoli
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714

7.  Remission of membranoproliferative glomerulonephritis type I with the use of tacrolimus.

Authors:  Maha Haddad; Keith Lau; Lavjay Butani
Journal:  Pediatr Nephrol       Date:  2007-07-03       Impact factor: 3.714

8.  Nodular mesangial lesions, marked mesangiolysis, and fingerprint deposits of unknown origin in a patient with nephrotic syndrome: a unique combination of glomerular lesions.

Authors:  Hiroshi Ohtani; Hideki Wakui; Atsushi Komatsuda; Shin Okuyama; Rie Masai; Nobuki Maki; Akihiko Kigawa; Ken-Ichi Sawada
Journal:  Clin Exp Nephrol       Date:  2006-06       Impact factor: 2.617

9.  Outcome of patients with primary immune-complex type mesangiocapillary glomerulonephritis (MCGN) in Cape Town South Africa.

Authors:  Ikechi G Okpechi; Thandiwe A L Dlamini; Maureen Duffield; Brian L Rayner; George Moturi; Charles R Swanepoel
Journal:  PLoS One       Date:  2014-11-20       Impact factor: 3.240

10.  A case of membranoproliferative glomerulonephritis associated with metastatic colon cancer.

Authors:  Jung-Hwa Ryu; Soon Sup Chung; Dong-Ryeol Ryu; Seung-Jung Kim; Duk-Hee Kang; Sun Hee Sung; Kyu-Bok Choi
Journal:  Korean J Intern Med       Date:  2013-02-27       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.